Do ETAreceptors participate in the hemodynamic and renal effects of chronic nitric oxide blockade?

Journal of Cardiovascular Pharmacology

Volumn 26, Issue , 1995, Pages S462-S465

  Fujihara, Clarice Kazue ^a   De Nucci, Gilberto ^b   Zatz, Roberto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

ETAreceptor; Nitric oxide; Rat; Renin angiotensin system

Indexed keywords

2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; ARGININE; AZEPINE DERIVATIVE; DRUG DERIVATIVE; ENDOTHELIN A RECEPTOR; ENDOTHELIN RECEPTOR; INDOLE DERIVATIVE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; 2 [[2 [[2 [[ (HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; DRINKING WATER; ENDOTHELIN RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; HEMODYNAMICS; KIDNEY; MALE; PHYSIOLOGY; RAT; WISTAR RAT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; GLOMERULUS BASEMENT MEMBRANE; HYPERTENSION; KIDNEY BLOOD FLOW; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR BINDING; RENAL SYSTEM PARAMETERS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALS; ARGININE; AZEPINES; HEMODYNAMIC PROCESSES; INDOLES; KIDNEY; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN;

EID: 0028844228     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/00005344-199526003-00136     Document Type: Article

References (26)

1. Ribeiro MO, Antunes E, De-Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension 1992:20:298-303.
2. Fujihara CK, Michellazzo SM, de-Nucci G, Zatz R. Sodium excess aggravates hypertension and renal parenchymal injury in rats with chronic NO inhibition. Am J Physiol 1994: 266:F697-705.
3. Fujihara CK, De Nucci G, Zatz R. Chronic nitric oxide inhibition aggravates glomerular injury in rats with subtotal nephrectomy. J Am Soc Nephrol 1995:5:1498-507.
4. Qiu C, Engels K, Baylis C. Angiotensin II and alpha 1-adrenergic tone in chronic nitric oxide blockade-induced hypertension. Am J Physiol 1994;266:R1470-6.
5. Badr KF, Murray JJ, Breyer MD, Takahashi K, Inagami T, Harris RC. Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathways. J Clin Invest 1989:83:336-42.
6. Benigni A, Zoja C, Corna D, et al. A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int 1993:44:440-4.
7. Takahashi K, Ghatei MA, Lam HC, O'Halloran DJ, Bloom SR. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 1990:33:306-10.
8. Kon V, Sugiura M, Inagami T, Harvie BR, Ichikawa I, Hoover RL. Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int 1990:37:1487-91.
9. Areceptor antagonist. J Pharmacol Exp Ther 1993:264:1040-6.
10. Maddox DA, Price DC, Rector FC Jr. Effects of surgery on plasma volume and salt and water excretion in rats. Am J Physiol 1977;233:F600-6.
11. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circulation 1980:41:1-9.
12. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992:90:278-81.
13. Lemne CE, Lundeberg T, Theodorsson E, Defaire U. Increased basal concentrations of plasma endothelin in borderline hypertension. J Hypertens 1994:12:1069-74.
14. A-receptor antagonist, attenuates hypoxic pulmonary hypertension in rats. Am J Physiol 1994;266:H1327-31.
15. Lanese DM, Conger JD. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J Clin Invest 1993:91:2144-9.
16. Perico N, Dadan J, Remuzzi G. Endothelin mediates the renal vasoconstriction induced by cyclosporine in the rat. J Am Soc Nephrol 1990:1:76-83.
17. Moller S, Emmeluth C, Henriksen JH. Elevated circulating plasma endothelin-1 concentrations in cirrhosis. J Hepatol 1993:19:285-90.
18. Areceptor antagonist. FR139317, ameliorates cerebral vasospasm in dogs. Life Sci 1993:52:1869-74.
19. Zimmerman RS, Maymind M, Barbee RW. Endothelin blockade lowers total peripheral resistance in hemorrhagic shock recovery. Hypertension 1994:23:205-10.
20. Fujihara CK, De Nucci G, Zatz R. Physiologic role of endothelin on the regulation of renal and systemic hemodynamics in the rat [Abstract]. J Am Soc Nephrol 1994: 5:603.
21. Yamada K, Yoshida S. Role of endogenous endothelin on renal functions in rats. Am J Physiol 1991;260:F34-8.
22. Wellings RP, Corder R, Warner TD, Cristol JP, Thiemermann C, Vane JR. Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney. Br J Pharmacol 1994:111:515-20.
23. Breceptors mediate contraction to endothelin-1 in human blood vessels. Circulation 1994:89:1203-8.
24. Qiu C, Samsell L, Baylis C. Actions of endogenous endothelin (ET) on renal hemodynamics in the normal rat [Abstract], J Am Soc Nephrol 1994: 5:610.
25. Yukimura T, Yamashita Y, Miura K, et al. Renal vasodilating and diuretic actions of a selective endothelin ET(B) receptor agonist, IRL1620. Eur J Pharmacol 1994:264:399-105.
26. Benigni A, Zoja C, Corna D, Orisio S, Remuzzi G. Role of renal endothelin in experimental progressive renal disease [Abstract]. J Am Soc Nephrol 1994: 5:573.